Eugene Bauer - 16 Apr 2026 Form 4 Insider Report for Evommune, Inc. (EVMN)

Reporting relationship: Chief Medical Officer, Director
Issuer ticker: EVMN
Reported as of: 16 Apr 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 17 Apr 2026, 17:23:59 UTC
Prior SEC filing: 11 Dec 2025
Source filing: View source filing
Reporting owner signature: /s/ Gregory S. Moss, Attorney-in-Fact

Key filing fact

Eugene Bauer filed Form 4 for Evommune, Inc. (EVMN) on 17 Apr 2026.

Key facts

This page summarizes Eugene Bauer's Form 4 filing for Evommune, Inc. (EVMN).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 17 Apr 2026, 17:23.

Change

Previous filing in this sequence was filed on 11 Dec 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001678620 Primary reporting owner

Bauer Eugene

Relationship: Chief Medical Officer, Director
Address: C/O EVOMMUNE, INC., 1891 PAGE MILL ROAD, PALO ALTO
Signature: /s/ Gregory S. Moss, Attorney-in-Fact
Signature date: 17 Apr 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

EVMN transaction Derivative

Employee Stock Option (Right to Buy)

Award

Transaction value
Shares: +51,117
Change %
Price: $0.000000^*
Shares after: 51,117
Date: 16 Apr 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 51,117
Exercise price: $26.77
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

One fourth (1/4) of the shares subject to the option award shall vest on the first anniversary of the grant date and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continuous service through such vesting date.